文献速递慢性肾脏病

肾内科医生视角下局限性肾肿物的评估与管理:核心教程2025

The Nephrologist's Perspective in Evaluation and Management of Localized Renal Masses: Core Curriculum 2025.
PubMed 文献 · Am J Kidney Dis · 2025-09-05

本文为肾内科核心教程,阐述局限性肾肿物(以透明细胞肾细胞癌为主)的评估与管理进展。局限性肿瘤肿瘤学生存率接近100%,生存更与包括慢性肾脏病(CKD)在内的基础合并症相关。与根治性肾切除术相比,部分肾切除术与更高的生存率和更好的肾功能保留相关。消融治疗和主动监测是手术风险较高患者的替代选择。肾内科医生在保留肾功能方面作用关键,早期参与多学科协作是理想策略。

要点

  • 局限性肾肿瘤肿瘤学生存率接近100%,生存更与CKD等合并症相关。
  • 与根治性肾切除术相比,部分肾切除术与更高生存率和更好肾功能保留相关。
  • 消融治疗和主动监测是手术风险较高患者的替代选择。

核心结论

  • 肾内科医生在具有CKD危险因素或存在基础CKD的局限性肾肿物患者中保留肾功能的作用对患者健康至关重要。
  • 早期肾内科参与包括泌尿外科、放射科、病理科及可能肿瘤科(晚期疾病)的多学科协作,是既根除肾癌又优化最大程度肾功能保留的理想治疗策略。

研究设计与样本

  • 本文为2025年核心教程(Core Curriculum),综述局限性肾肿物的评估与管理。

主要发现

  • 局限性肿瘤的肿瘤学生存率接近100%,生存更与包括CKD在内的基础合并症密切相关。
  • 与根治性肾切除术相比,部分肾切除术与更高的生存率和更好的肾功能保留相关。
  • 消融治疗和主动监测是手术风险较高患者的替代选择。

临床怎么用

  • 肾内科医生不负责确定确切治疗方式,但在具有CKD危险因素或存在基础CKD的患者中保留肾功能的作用至关重要。
  • 早期肾内科参与包括泌尿外科、放射科、病理科及可能肿瘤科(晚期疾病)的多学科协作是理想治疗策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The evaluation and management of renal masses, predominantly of the clear cell renal cell carcinoma subtype, have been evolving over the past several years and demanding greater attention from nephrologists. Oncologic survival of localized tumors approaches 100%, where survival is more closely tied to underlying comorbidities including chronic kidney disease (CKD). Early diagnosis and thus increasing prevalence related to incidental discovery of renal masses allows greater emphasis on nephron-sparing procedures and for residual kidney function preservation. Compared with radical nephrectomy, partial nephrectomy is associated with higher survival and greater preservation of kidney function. Ablative therapies and active surveillance are alternative options for patients with higher surgical risk. Although it is not in the purview of the nephrologist to determine the exact therapy, our role in the preservation of kidney function for these patients who have CKD risk factors or with underlying CKD is crucial for the well-being of the patient. Early nephrology partnership in a multidisciplinary approach with the treatment team including the urologist, radiologist, pathologist, and potentially the oncologist (with advanced disease) is the ideal treatment strategy for eradication of their kidney cancer while optimizing conditions for maximal kidney function preservation.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Tillquist K, Shringi S, Chang A, et al. The Nephrologist's Perspective in Evaluation and Management of Localized Renal Masses: Core Curriculum 2025. Am J Kidney Dis. 2025. PMID: 40910966. doi:10.1053/j.ajkd.2025.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。